top of page
Articles and Research Papers for University-Level Study


Autodesk Inc. (ADSK) and Cooper Cos. (COO) business updates and stock performance
Stock market information for Autodesk Inc. (ADSK)


How Hedge Funds Won Big on an Obscure Drugmaker
In the high stakes world of hedge funds, where billions of dollars can be gained or lost in moments, obscure opportunities often separate winners from losers. Few events in recent years highlight this dynamic as dramatically as the extraordinary surge of Abivax, a little-known French biotechnology company. In a single day, Abivax shares skyrocketed almost 600%, transforming the fortunes of several hedge funds that had been struggling in the red. The story of how these funds c


A Startup That Uses AI to Spot Financial Fraud Raises $60 Million
Financial fraud has always been a high-stakes game, with criminals constantly devising new methods to stay ahead of regulators. From...


Why Some AI Startup Firms Are Moving Their Operations from San Francisco to New York
For more than a decade, San Francisco has been considered the beating heart of the global startup ecosystem. Silicon Valley and the Bay Area became synonymous with technology innovation, drawing billions of dollars in venture capital and attracting top talent from around the world. Artificial intelligence startups in particular flourished in this environment, benefiting from proximity to tech giants like Google, Meta, and OpenAI.


Supply-Chain Tech Firm Overhaul Raises $105 Million to Expand Freight Tracking and Cargo Theft Prevention
Supply-chain technology firm Overhaul has announced the successful completion of a $105 million funding round as it accelerates its...


Advent International to Buy U-blox for $1.3 Billion
Advent International, one of the world’s leading private equity firms, announced it has reached an agreement to acquire U-blox, a Swiss provider of wireless communication and positioning semiconductors, in a deal valued at approximately $1.3 billion. The transaction will be executed through a public tender offer, giving Advent control of U-blox, which trades on the Swiss stock exchange under the ticker symbol UBXN .


Peabody Calls Off $3.78 Billion Deal to Buy Anglo American’s Australian Coal Assets
Peabody Energy, one of the largest coal producers in the world, shocked the energy sector when it announced that it had called off its $3.78 billion deal to acquire Anglo American’s Australian steelmaking coal operations. The agreement, which had been hailed as one of the most significant coal industry transactions of the year, collapsed after a central mine included in the acquisition package was forced into shutdown. This decision represents a major blow not only to Anglo A


Sinclair Proposes Merger With Tegna: A Landmark Deal in Local Television Broadcasting
The American media industry is entering a new era defined by rapid consolidation, technological disruption, and evolving consumer habits. In this changing landscape, Sinclair Broadcast Group, one of the largest owners of local television stations in the United States, has proposed a merger with Tegna, another powerhouse in the broadcasting sector. If completed, this deal could reshape the competitive dynamics of the local TV market, creating one of the most expansive broadcas


How ‘KPop Demon Hunters’ Became Netflix’s Most Watched Movie Ever
When KPop Demon Hunters popped onto Netflix on June 20, 2025, it arrived as something that looked at once familiar and refreshingly new: an animated musical built around a fictional K-pop girl group called HUNTR/X that also happens to moonlight as demon hunters. It mixed bright, kinetic animation with the rituals of fandom, layered the narrative with themes of friendship and courage, and scored itself with pop songs so sticky they became part of the cultural hum. The result


Mohammad Hakimi, PhD Student in Marketing. A Profile of Ambition, Research, and Leadership
Mohammad Hakimi’s name appears quietly in the academic registers of Iowa State University’s Ivy College of Business, but the simple directory entry understates a larger story: that of a student who has chosen the long, exacting path of doctoral research in marketing and who is building the kinds of habits that lead to scholarship, teaching, and institutional contribution. Public university records list Mohammad Hakimi (sometimes shown as Mohammad Hakimi Asiabar) as a doctoral


Charlotte Wickert, PhD Student Who Was Named 2022-23 Goldwater Scholar: Now Scientist Musician Bridging Reactor Physics and Reinvention
Charlotte Wickert’s story reads like a thoughtful balancing act between two worlds that many people assume are distinct: the rigorous,...


Dr. Lina Song: Harvard PhD Graduate Turned Founder and CEO of AI Startup Doogooda
Lina Song is a Model, Founder, and Assistant Professor of Operations and Technology at the University College London School of Management . Lina’s research interests include providing operations management insight to public policy decision-making problems. With her experience and academic rigour she has the ability to advise company’s on how to design policy levers to improve the delivery of social goods and services. Lina Song completed her Ph.D. at Harvard University Gra


Human Resource Management for Small Businesses
Human resource management (HRM) practices are the important organizational factor that affects employee attitude and behavior performance ( Zhao, H. et al., 2023). Companies that go through rapid growth, and expands its workforce, along with scaling to foreign countries goes through challenges throughout the process as it can become difficult to maintain employee retention, satisfaction, ad productivity. To address these challenges, a businesses Human Resource (HR) department


BioNTech SE ADR Rises 18%, Outperforms Market
On June 2, 2025 BioNTech SE’s American depositary receipt staged a dramatic one-day rally, closing up 18.0% at $113.10. The move came on an otherwise modestly positive day for U.S. equities, with the S&P 500 and Dow Jones Industrial Average advancing only fractionally ( MarketWatch ). What made BioNTech’s performance remarkable was not just the magnitude of the gain but also the unusually high trading volume: roughly 5.3 million shares exchanged hands, far above the company’s


US Credit Card Defaults Jump to Highest Level Since 2010
The United States is witnessing a troubling resurgence in credit card defaults, a phenomenon that has reached levels not seen since the aftermath of the 2008 global financial crisis. Data from major financial institutions and credit rating agencies indicates that the rate of consumers failing to meet their credit card obligations has climbed steadily over the past two years, with 2025 marking a significant tipping point. This surge is raising alarm bells for policymakers, len


Sanofi to Buy US Blood Disorder Drugmaker for Up to $9.5 Billion
French pharmaceutical giant Sanofi on June 2, 2025 announced an agreement to acquire Blueprint Medicines, a U.S.-based biopharma company known for its work on KIT-driven diseases and systemic mastocytosis, in a deal valued at roughly $9.1 billion in cash up front and up to about $9.5 billion including contingent milestone payments ( Reuters ). The transaction—priced at $129 per share in cash plus contractual contingent rights tied to future milestones—represents a bold strate


German Asset Manager Divests Exxon Shares Over Insufficient Climate Commitment
In early June 2025, Union Investment, one of Germany’s largest asset managers, announced it had divested its holdings in ExxonMobil and EOG Resources after concluding that the companies had not demonstrated adequate climate commitments—most notably, a willingness to address Scope 3 emissions, which arise from the end use of fossil fuels rather than from a company’s own operations ( Financial Times ). The decision was framed not as ideological posturing but as a measured step


Bristol Myers Squibb Signs $11 Billion Cancer Drug Deal with BioNTech: What It Means for the Pharma Landscape
Bristol Myers Squibb and BioNTech announced a landmark strategic partnership in mid-2025 to co-develop and co-commercialize a next-generation bispecific antibody candidate aimed at multiple solid tumor types ( Reuters ). The headline figure, an agreement that could total roughly $11.1 billion captures attention because it signals a major legacy oncology company doubling down with an mRNA-era innovator on a therapy designed to combine immune activation with vascular targeting


Morgan Stanley: Why Nvidia Stands Out as a Unique Investment Case
Morgan Stanley has long been among the most vocal Wall Street shops when it comes to semiconductors and AI infrastructure, and its recent commentary on Nvidia reads like a concentrated thesis: Nvidia is not just another chipmaker; it occupies a distinct, arguably irreplaceable, position in the unfolding AI economy. The firm has reaffirmed an Overweight rating on Nvidia and lifted its price expectations in recent notes, framing the company’s Blackwell-era product cycle and hyp


1 Stock to Buy, 1 Stock to Sell This Week: Broadcom (Buy) and Lululemon (Sell)
Investors looking for a clear, research-backed trade idea this week should consider Broadcom as a buy and Lululemon as a sell. Broadcom is riding a wave of accelerating AI-related demand that shows up in its most recent quarterly results, forward guidance, and an outpouring of analyst upgrades tied to semiconductor spending by hyperscalers. Lululemon, by contrast, is exhibiting classic consumer-retail warning signs: rapidly rising inventories, slowing growth in the face of a


What Is the Doctoral Dissertation Process Like?
The doctoral dissertation is the culminating milestone of a long academic journey, the moment when a student demonstrates that they have met the curricular and specialization requirements of their program. For many, the dissertation is less a single event and more a prolonged process of discovery, argumentation, and professional maturation. It asks the student to synthesize years of coursework, reading, and apprenticeship into an independent project that contributes new knowl


Goldman Says Hedge Funds Are Buying U.S. Tech Stocks at the Fastest Pace in a Decade
When Goldman Sachs flags a clear directional shift in hedge fund positioning, investors take notice. In late spring 2025 the firm’s prime brokerage and flow desks began reporting a striking pattern ( Reuters ). Hedge funds were accumulating U.S. technology stocks at a rate not seen in roughly ten years. That surge in demand helped power some of the strongest market performance in recent months and focused attention on how professional investors are allocating capital into the


After the TACO Trade, Here Comes the “Trump Collar.” What That Means for Stocks
When markets opened lower on June 2, 2025, a familiar pattern was on display: a burst of volatility tied to tariff-related rhetoric, followed by a cooling-off period and a partial rebound as policy signals softened. MarketWatch described the new episode and highlighted a fresh market shorthand from Nomura strategist Charlie McElligott, the “Trump collar.” ( MarketWatch ). The phrase captures how abrupt policy threats and later reassurances have combined to squeeze markets int


Credit Spreads Haven't Looked This Good Since the 2000s. Can They Get Better?
Credit markets closed 2024 on a high note. After years of volatility driven by pandemic shocks, rampant inflation, and aggressive monetary tightening, corporate credit spreads tightened meaningfully as investors pushed into yield-bearing assets and companies took advantage of a buyer-friendly backdrop to refinance and issue new debt. Headlines described spreads at levels not seen since the mid-2000s, and a record wave of issuance accompanied that move as borrowers raced to lo
bottom of page